Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Article

J App Pharm Sci. 2020; 10(4): 100-112


Formulation and stability studies of Metformin Hydrochloride in a controlled porosity osmotic pump system

Hanan M. Hashem, Aya R. Abdou, Nesrin F. Taha, Nadia M. Mursi, Laila H. Emara.

Abstract
This study was designed to formulate, for the first time, Metformin Hydrochloride (MH, 850 mg/tablet) as a controlled porosity osmotic pump (CPOP) system to achieve zero-order release pattern. MH core tablet was coated with cellulose acetate membrane containing PEG 400. The effect of different percentages and molecular weights (900K and 4M) of Polyethylene oxide (PEO, 900K and 4M) in tablet core was studied. The release studies were done in phosphate buffer pH 6.8 using USP apparatus II and phosphate buffer pH 6.8 were used for the release studies, meanwhile a promising formula was tested in biorelevant media. Stability of some selected formulationse was carried-out for 6 months, at bench and accelerated conditions. Evaluation included: MH content, DSC, SEM, drug release and kinetics. Results revealed that increasing PEO percentage within the core drove to decreased MH release. SEM confirmedverified formation of pores in the membrane that accounts for MH release. Almost all stored tablets were stable for all studied parameters. MH endothermic peak maintained its position and energy of enthalpy upon storage as confirmed by DSC. MH release rate from a promising formula, following zero-order release model, increased by 28% in biorelevant media compared to phosphate buffer. Subsequently, in vitro release in biorelevant media could be employed as a tool to anticipate in vivo tone of CPOP formulationse.

Key words: Controlled porosity osmotic pump, Metformin Hydrochloride, Biorelevant media, FaSSGF, FaSSIF, Stability studies.


Full-text options

Full-text Article




Advertisement


SUBMIT YOUR ARTICLE NOW




ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.